Table 3 -.

Sociodemographic and Medical Variables for Single-Arm Trial Participants

	Survivor (N=12)		Partner (N=12)		Total (N=24)
	Mean (SD)	% (n)	Mean (SD)	% (n)	Mean (SD)	% (n)
Age (years)	58.9 (10.9)		62.7 (10.4)		60.8 (10.6)
Race
African American		16.7% (2)		16.7% (2)		16.7% (4)
Caucasian/White		83.3% (10)		83.3% (10)		83.3% (24)
Ethnicity
Non-Hispanic		100% (12)		91.7% (11)		95.8% (23)
Hispanic		0% (0)		0% (0)		0% (0)
Not reported		0% (0)		8.3% (1)		4.2% (1)
Education
High school diploma/GED		25.0% (3)		16.7% (2)		20.8% (5)
Some college		41.7% (5)		8.3% (1)		25.0% (6)
Bachelor’s degree		25.0% (3)		66.7% (8)		45.8% (11)
Master’s degree		8.3% (1)		8.3% (1)		8.3% (2)
Employment status
Employed, full or part time		58.3% (7)		58.3% (7)		58.3% (14)
Retired		33.3% (4)		41.7% (5)		37.5% (9)
On disability		8.3% (1)		0.0% (0)		4.2% (1)
Married		100% (12)		100% (12)		100% (24)
Length of relationship (years)	30.9 (12.8)		31.9 (13.3)		31.4 (12.7)
Household size (people)	2.9 (1.9)		3.0 (1.9)		3.0 (1.7)
Time since diagnosis (months)	20.6 (10.4)
Cancer Stage
I		41.7% (5)
II		33.3% (4)
III		25.0% (3)
Cancer treatments (%)
Chemotherapy		66.7% (8)
Radiation		66.7% (8)
Hormonal Therapy		91.7% (11)
Surgery (Mastectomy)		50.0% (6)
Surgery (Lumpectomy)		63.6% (7)
Comorbidities (ACE-27)
None		16.7% (2)
Mild		16.7% (2)
Moderate		50.0% (6)
Severe		16.7% (2)
Specific Comorbidities
Hypertension		75.0% (9)		33.3% (4)		54.2% (13)
Heart Disease		8.3% (1)		33.3% (4)		20.8% (5)
Rheumatoid Arthritis		8.3% (1)		8.3% (1)		8.3% (2)
Osteoarthritis		25.0% (3)		16.7% (1)		20.8% (5)
Diabetes		25.0% (3)		50.0% (6)		37.5% (9)
Sciatica		8.3% (1)		0.0% (0)		4.2% (1)
Pulmonary issues		33.3% (4)		16.7% (2)		25.0% (6)
Other Cancers		33.3% (4)		16.7% (2)		25.0% (6)

Note- GED: Tests of General Educational Development; ACE-27: Adult Comorbidity Evaluation 27